Induction of apoptosis in HeLa cells via caspase activation by resveratrol and genistein

Journal of Medicinal Food

Volumn 16, Issue 2, 2013, Pages 139-146

  Dhandayuthapani, Sivanesan ^a   Marimuthu, Palanisamy ^b   Hörmann, Vanessa ^c   Kumi Diaka, James ^c   Rathinavelu, Appu ^a,b  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

^c FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

apoptosis; caspase 3; caspase 9; DNA fragmentation; genistein; HDM2 mRNA expression; HeLa cells; mitochondrial membrane potential; resveratrol

Indexed keywords

CASPASE 3; CASPASE 9; GENISTEIN; PROTEIN MDM2; RESVERATROL;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; ENZYME ACTIVITY; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CASPASE 3; CASPASE 9; ENZYME ACTIVATION; GENISTEIN; HELA CELLS; HUMANS; PROTO-ONCOGENE PROTEINS C-MDM2; STILBENES;

EID: 84873651436     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.0141     Document Type: Article

References (35)

1. Franco EL, Schlecht NF, Saslow D: The epidemiology of cervical cancer. Cancer J 2003;9:348-359. (Pubitemid 44403488)
2. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
3. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
4. Frankfurt OS, Krishan A: Apoptosis-based drug screening and detection of selective toxicity to cancer cells. Anti-cancer Drugs 2003;14:555-561. (Pubitemid 37083161)
5. Shih A, Davis FB, Lin H-Y, Davis PJ: Resveratrol induces apoptosis in thyroid cancer cell line via a MAPK and p53 dependent mechanism. J Clin Endocrinol Metab 2002;87: 1223-1232. (Pubitemid 36121092)
6. Fukuhara K, Miyata N: Resveratrol as a new type of DNA-cleaving agent. Bioorg Med Chem Lett 1998;8:3187-3192. (Pubitemid 28551644)
7. Hsieh TC, Wu JM: Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp Cell Res 1999;249:109-115. (Pubitemid 29394029)
8. Hsieh TC, Juan G, Darzynkiewicz Z, Wu ZM: Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p 21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res 1993;59:2596-2601.
9. Ng AP, Nin DS, Fong JH, Venkataraman D, Chen CS, Khan M: Therapeutic targeting of nuclear receptor corepressor misfolding in acute promyelocytic leukemia cells with genistein. Mol Cancer Ther 2007;6:2240-2248. (Pubitemid 47294752)
10. Debatin KM: Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother 2004;53:153-159.
11. Kim R, Tanabe K, Uchida Y, Emi M, Inoue H, Toge T: Current status of the molecular mechanisms of anticancer drug induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. Cancer Chemother Pharmacol 2002;50:343-352. (Pubitemid 35440522)
12. Barnhart BC, Alappat EC, Peter ME: The CD95 type I/type II model. Semin Immunol 2003;15:185-193. (Pubitemid 38155825)
13. Boatright KM, Salvesen GS: Mechanisms of caspase activation. Curr Opin Cell Biol 2003;15:725-731. (Pubitemid 37492933)
14. Vassilev LT, Vu BT, Graves B, et al.: In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004;303:844-848. (Pubitemid 38174664)
15. Onel K, Cordon-Cardo C: MDM2 and prognosis. Mol Cancer Res 2004;2:1-8. (Pubitemid 38167102)
16. Rathinavelu P, Malave A, Raney SR, Hurst J, Roberson CT, Rathinavelu A: Expression of mdm-2 oncoprotein in the primary and metastatic sites of mammary tumor (GI-101) implanted athymic nude mice. Cancer Biochem Biophys 1999;17:133-146. (Pubitemid 29475253)
17. Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature 2000;408:307-310.
18. Matsumoto R, Tada M, Nozaki M, Zhang CL, Sawamura Y, Abe H: Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms. Cancer Res 1998;58:609-613. (Pubitemid 28099465)
19. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH: Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991;254:277-279. (Pubitemid 21917340)
20. Kaur K, Pervez FF, Jasani V, Bukhari N, Narasimhan M, Rathinavelu A: Induction of apoptosis by resveratrol in cancer cells during combination treatment with nutlin-3 and TGF-b. In: Miami Winter Symposium, 2006 Proceedings, University of Miami Leonard M. Miller School of Medicine, Miami, 2006.
21. Cao ZJ, Xia C, Shi X, Jiang B-H: Trans-3,4,5-trihydroxystibene inhibits hypoxia-inducible factor-1 and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res 2004;10:5253-5263. (Pubitemid 39099800)
22. Henkels MH, Turchi JJ: Cisplatin induced apoptosis proceeds by caspase-3 dependent and independent pathways in cisplatin resistant and sensitive human ovarian cancer cell line. Cancer Res 1999;59:3077-3083. (Pubitemid 29316005)
23. Dörrie J, Gerauer H, Wachter Y, Zunino SJ: Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res 2001;61:4731-4739. (Pubitemid 32691883)
24. Hongzhong W, Yu Z, Chonghua L, Liping X, Guang C, Yan-cheng N, Rongqing Z: Effects of genistein on cell cycle and apoptosis of two murine melanoma cell lines. Tsinghua Sci Technol 2007;12:372-380.
25. Zamzami N, Marchetti P, Castedo M, et al.: Reduction in mito-chondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 1995;181:1661-1672.
26. Ly JD, Grubb DR, Lawen A: The mitochondrial membrane potential (dwm) in apoptosis; an update. Apoptosis 2003;8:115-128. (Pubitemid 36553052)
27. Marchetti P, Castedo M, Susin SA, et al.: Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 1996;184:1155-1160. (Pubitemid 26313572)
28. 0- tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 1993;197:40-45. (Pubitemid 23358874)
29. Hyun-Eui Kim, Fenghe Du, Min Fang, and Xiaodong Wang: Formation of apoptosome is initiated by cytochrome C-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1. Proc Natl Acad Sci 2005;102:17545-17550. (Pubitemid 41803534)
30. Susin S, Zamzami N, Castedo M, et al.: The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95-and ceramide-induced apoptosis. J Expt Med 1997;186:25-37. (Pubitemid 27304844)
31. Gosslau A, Chen KY: Nutraceuticals, apoptosis, and disease prevention. Nutrition 2004;20:95-102. (Pubitemid 38091587)
32. Mehdi SJ, Ahmad A, Irshad M, Manzoor N, Rizvi MMA: Cy-totoxic effect of carvacrol on human cervical cancer cells. Biol Med 2011;3:307-312.
33. Dubs-Poterszman M.C, Tocque B, Wasylyk B: MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell-cycle arrest. Oncogene 1995;11:2445-2449. (Pubitemid 26008423)
34. Nelson DM, Bhaskaran V, Foster WR, Lehman-Mc Keeman LD: p53 Independent induction of rat hepatic Mdm2 following administration of phenobarbital and pregnenolone 16 alpha-carbonitrile. Toxicol Sci 2006;94:272-280. (Pubitemid 44817143)
35. Jones, SN, Hancock AR, Vogel H, Donehower LA, Bradley A: Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc Natl Acad Sci USA 1998; 95:15608-15612. (Pubitemid 29018747)